21st Austria weekly - ATX TR at 7131.07 - RHI Magnesita, Palfinger and Lenzing best-performing, RBI with weakest performance (04/02/2023)

This week in our 21st Austria weekly: Week 5 brought for ATX TR a consolidation on high level, the index closed slightly better at 7131. Best stock in ATX Prime was RHI Magnesita, who entered the Index Watchlist at position 13 when it comes to Market Cap. News came from Austriacard, Croma-Pharma, ams Osram, Pierer Mobility, Uniqa, Palfinger, Andritz, CA Immo, RBI, AT&S, Austrian Post, Siemens AG Österreich and Kontron . 

BSNgine weekly Spitout: The ATX TR up 0,2% to 7.131,07 points this week. Year-to-date the ATX TR is now at 8,09%. Up to now there were 18 days with a positive and 7 with a negative gain. From the year-high we are 0,18% away, from the low 8,09%. Statistically the best weekday so far 2023 is Friday with 0,48%, the weakest is Thursday with 0,13%.

These are the best-performers this week: RHI Magnesita 5,77% in front of Palfinger 4,93% and Lenzing 4,88%. And the following stocks performed worst: RBI -9,89% in front of Marinomed Biotech -7,56% and OMV -5,09%.

Further highlights this week: EVN for 6 days in a row up (3,23% gain from 19,18 to 19,8), also Österreichische Post 4 days up (2,77% gain from 32,5 to 33,4), Telekom Austria 4 days up (2,13% gain from 6,1 to 6,23), voestalpine 3 days up (2,63% gain from 30,4 to 31,2), Mayr-Melnhof 3 days up (2,6% gain from 153,8 to 157,8), Palfinger 3 days up (3,42% gain from 27,8 to 28,75), Polytec Group 3 days up (3,7% gain from 4,86 to 5,04), RHI Magnesita 3 days up (7,14% gain from 30,8 to 33), RBI 6 days down (10,42% loss from 17,09 to 15,31), Bawag 3 days down (1,24% loss from 56,65 to 55,95), Marinomed Biotech 3 days down (8,62% loss from 52,2 to 47,7), OMV 3 days down (5,61% loss from 45,85 to 43,28).

Best-performers year-to-date as of now: UBM 32,46% (last year: -47,34 percent) followed by RHI Magnesita 27,41% (last year: -34,1 percent) and voestalpine 25,91% (last year: -22,56 percent). And the worst-performing stocks year-to-date: Marinomed Biotech -15,43% (Vorjahr: -35,91 percent), followed by OMV -10,02% (Vorjahr: -3,7 percent) and Frequentis -7,37% (Vorjahr: 6,74 percent).

High above the MA200: voestalpine 32,87%, RHI Magnesita 32,14% and Erste Group 30%.
Down under the MA200: S Immo -33,89%, Marinomed Biotech -24,28% and AT&S -22,86%.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (04/02/2023)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Plausch S4/29: Börsentag in Wien, der Evotec-Boss und die DAX-Legionärs-Elf mit Daniel Riedl und Thomas Schaufler

Bildnachweis

1. 21st Austria Weekly

Aktien auf dem Radar:Addiko Bank, Immofinanz, Andritz, Marinomed Biotech, RHI Magnesita, Warimpex, Bawag, Österreichische Post, SBO, S Immo, Agrana, AMS, Frequentis, Wolford, Oberbank AG Stamm, Deutsche Bank, Beiersdorf, Münchener Rück, Rheinmetall, Vonovia SE, Brenntag, Commerzbank, HeidelbergCement, Sartorius, E.ON , Deutsche Boerse, Ahlers, OMV, Erste Group.

Random Partner

---

Kontron
Der Technologiekonzern Kontron AG – ehemals S&T AG – ist mit mehr als 6.000 Mitarbeitern und Niederlassungen in 32 Ländern weltweit präsent. Das im SDAX® an der Deutschen Börse gelistete Unternehmen ist einer der führenden Anbieter von IoT (Internet of Things) Technologien. In diesen Bereichen konzentriert sich Kontron auf die Entwicklung sicherer und vernetzter Lösungen durch ein kombiniertes Portfolio aus Hardware, Software und Services.

>> Besuchen Sie 65 weitere Partner auf boerse-social.com/partner